Biopharma

Pharma's reputation would improve if drugmakers offered digital health services, patients say

Pharma's reputation would improve if drugmakers offered...

Apr 1, 2025 0

Patients are looking to pharmaceutical companies to offer healthcare services be...

RNA editing biotech Airna adds $155M in funding

RNA editing biotech Airna adds $155M in funding

Apr 1, 2025 0

Airna will use the Series B round to launch a Phase 1/2 trial of its lead progra...

Minutes of the CAT meeting 19-21 February 2025

Apr 1, 2025 0

Minutes of the CAT meeting 19-21 February 2025

SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 October 2024, 10:00 (CEST) to 4 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR ...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, ...

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance Management Service (SMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 October 2024, 10:00 (CEST) to 8 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Subst...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance Management Service (...

SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD) for MAH, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 October 2024, 10:00 (CEST) to 10 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Produ...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XE...

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2024, 10:00 (CEST) to 14 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Subst...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisati...

SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Service (RMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2024, 10:00 (CEST) to 7 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Refer...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Servic...

SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Service (OMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 October 2024, 10:00 (CEST) to 9 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Organ...

Apr 1, 2025 0

SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Servic...

Template - Request for advice on the orphan device stat...

Apr 1, 2025 0

Template - Request for advice on the orphan device status pursuant to Article 61...

Template - Request for advice on the clinical developme...

Apr 1, 2025 0

Template - Request for advice on the clinical development strategy or clinical d...

EMEA-003516-PIP01-23

EMEA-003516-PIP01-23

Apr 1, 2025 0

EMEA-003516-PIP01-23

Start of procedure: Extension of marketing authorisatio...

Apr 1, 2025 0

Start of procedure: Extension of marketing authorisation (28 February 2025 - 27 ...

Start of procedure: Type II variation - extension of in...

Apr 1, 2025 0

Start of procedure: Type II variation - extension of indication under evaluation...

Scientific advice and protocol assistance adopted durin...

Apr 1, 2025 0

Scientific advice and protocol assistance adopted during the CHMP meeting 24-27 ...

Procedural guidance to scientific committeesꞌ members a...

Apr 1, 2025 0

Procedural guidance to scientific committeesꞌ members and experts on completing ...

Handling competing interests

Handling competing interests

Apr 1, 2025 0

Handling competing interests

Lundbeck ends subcutaneous migraine cohort after futility review, pivots to IV formulation

Lundbeck ends subcutaneous migraine cohort after futili...

Apr 1, 2025 0

Lundbeck has stopped development of a subcutaneous formulation of its migraine d...

Opinion: Reduce drug spending by drastically simplifying monopolies on drugs

Opinion: Reduce drug spending by drastically simplifyin...

Apr 1, 2025 0

The Hatch Waxman Act and the Biological Price Competition and Innovation Act hav...

STAT+: The biotech scorecard for the second quarter: 24 stock-moving events to watch

STAT+: The biotech scorecard for the second quarter: 24...

Apr 1, 2025 0

Here is STAT’s biotech scorecard for the second quarter. Plus, a rundown of FDA-...

STAT+: Ambitious NIH drive to solve brain mysteries faces uncertain future

STAT+: Ambitious NIH drive to solve brain mysteries fac...

Apr 1, 2025 0

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $...

STAT+: HHS will not enforce gender and sexual orientation requirements for medical records

STAT+: HHS will not enforce gender and sexual orientati...

Apr 1, 2025 0

HHS will not enforce standards that medical records be able to capture patients’...

Rollout of ‘miracle’ HIV prevention drug is threatened by Trump cuts to global AIDS relief program

Rollout of ‘miracle’ HIV prevention drug is threatened ...

Apr 1, 2025 0

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which h...

Organisation chart: Veterinary Medicines

Apr 1, 2025 0

Organisation chart: Veterinary Medicines

47
48
49
50
51

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.